Stocks · Korea
389650
KOSDAQ
Nextbiomedical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+1.62%
1M+0.96%
3M-20.51%
6M-58.08%
1Y-57.97%
YTD-61.89%
52W high101,000원
52W low28,150원
From 52W high-68.91%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2024 | 95억 | -36억 | 29억 | -37.5% |
| 2025 | 165억 | -7억 | -3억 | -4.4% |
| Quarterly | ||||
| 2024 3Q | 22억 | -10억 | -13억 | -46.0% |
| 2025 1Q | 38억 | -7억 | -4억 | -17.7% |
| 2025 2Q | 40억 | 20,641,115원 | -9억 | 0.5% |
| 2025 3Q | 49억 | 4억 | 11억 | 7.5% |
| 2025 4Q | 38억 | -4억 | -49,791,802원 | -11.6% |
| 2026 1Q | 41억 | -12억 | -1억 | -28.9% |
Company
Address: 인천광역시 연수구 벤처로100번길 6
Peers in the same sector
Recent filings
- 2026-08-19[기재정정]분기보고서 (2026.03)
- 2026-08-10반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.